Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06747117 · ClinicalTrials.gov registry record

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

A clinical trial of Lower Extremity Acute Limb Ischemia and LE ALI, sponsored by Penumbra.

Recruiting
Registry status
300
Enrollment target
20
Study locations

NCT06747117 is a study of Lower Extremity Acute Limb Ischemia and LE ALI that is actively recruiting participants, run by Penumbra. The registered enrollment target is 300 participants. The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06747117, a study of Lower Extremity Acute Limb Ischemia and LE ALI, is actively recruiting participants, sponsored by Penumbra.

RECRUITING
Registry status
300 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).

Interventions

  • DEVICE Indigo Aspiration System

Study Locations (20)

Florida

  • University of Florida Shands Hospital - Gainesville
  • Radiology and Imaging Specialists - Lakeland
  • Baptist Hospital of Miami, Miami Cardiac and Vascular Institute - Miami

Ohio

  • TriHealth Good Samaritan Hospital - Cincinnati
  • Cleveland Clinic - Cleveland

South Carolina

  • Prisma Health Greenville Memorial Hospital - Greenville
  • Lexington Medical Center - West Columbia

Texas

  • Baylor St. Luke's Medical Center - Houston
  • Baylor Scott & White The Heart Hospital - Plano - Plano

Arizona

  • HonorHealth Scottsdale Osborn Medical Center - Scottsdale

California

  • Community Memorial Hospital - Ventura

Connecticut

  • Yale New Haven Hospital - New Haven

Delaware

  • Christiana Care Health Services, Inc. - Newark

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-05-18
Est. Completion 2029-01

Sponsor

Penumbra

25 total trials

What the Registry Record Tells You About NCT06747117

The ClinicalTrials.gov registry entry for NCT06747117 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lower Extremity Acute Limb Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Indigo Aspiration System is the first listed.

NCT06747117 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06747117 about?

NCT06747117 is a clinical study titled "A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)". The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).

What is the current status of trial NCT06747117?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-05-18. Estimated completion is 2029-01.

What conditions does trial NCT06747117 study?

This clinical trial studies the following conditions: Lower Extremity Acute Limb Ischemia, LE ALI.

What interventions are being tested in trial NCT06747117?

The interventions under investigation include: Indigo Aspiration System (DEVICE).

Who is sponsoring clinical trial NCT06747117?

This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06747117 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.